recurrent breast cancer Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)

Phase 1 (1)

Interventional (1)

Shanghai Pharmaceuticals Holding Co., Ltd (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadbreast cancer

I am/have/hadmetastasis

I am/have/hadstage iv breast cancer

I am/have/hadHER2

I am/have/hadmonoclonal antibody therapy

I am/have/hadejection fraction

I am/have/hadher2-positive breast cancer

I am/have/hadprimary tumor

I am/have/hadbone metastases

I am/have/hadmastectomy

I am/have/hadbilateral breast cancer

I am/have/hadher2/neu-positive breast cancer

I am/have/hadbiomarker analysis

added new label for I am/have/had

more

I am looking for

I am looking formonoclonal antibodies

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Females
Recruiting

B002 in Patients With HER2-positive Breast Cancer

To assess the safety and tolerability characteristics of B002 in patients with HER2-positive recurrent or metastatic breast cancer. The dose-limiting toxicity (DLT) was assessed and the maximum tolerated dose (MTD) was explored.

her2/neu-positive breast cancer

bone metastases

bilateral breast cancer

breast cancer

biomarker analysis

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.